Hepatic production of VLDL1 but not VLDL2 is related to insulin resistance in normoglycaemic middle-aged subjects

被引:67
|
作者
Gill, JMR
Brown, JC
Bedford, D
Wright, DM
Cooney, J
Hughes, DA
Packard, CJ
Caslake, MJ
机构
[1] Univ Glasgow, Dept Vasc Biochem, Glasgow G12 8QQ, Lanark, Scotland
[2] Food Res Inst, Norwich, Norfolk, England
关键词
VLDL; insulin sensitivity; lipoprotein kinetics; liver;
D O I
10.1016/j.atherosclerosis.2004.04.022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin resistance is probably the defining feature of the metabolic syndrome and is ail important determinant of plasma triglyceride (TG) concentrations. We sought to investigate whether insulin resistance influenced the metabolism of VLDL1 (Sf 60-400) and VLDL2 (Sf 20-60). Sixteen (eight men, eight women) middle-aged, normoglycaemic subjects participated. VLDL1 and VLDL2 apolipoprotein (apo) B metabolism was followed using a deuterated leucine tracer and insulin resistance was estimated using homeostasis model assessment (HOMA). HOMA-estimated insulin resistance (HOMA(IR)) significantly and strongly correlated with the VLDL1 production rate (r = 0.69, P < 0.01) and VLDL1 apo B pool size (r = 0.59, P = 0.02), but these relationships were not evident for VLDL2. Conversely, HOMAIR was not significantly related to the fractional rate of transfer of VLDL1 to VLDL2 but was significantly related to the fractional rate of transfer from VLDL2 to IDL (r = 0.61, P = 0.01). HOMA(IR) was not significantly related to the fractional rate of direct catabolism for either VLDL1 or VLDL2. These results suggest a role for insulin resistance in the determination of hepatic VLDL1 production and highlight the independent regulation of VLDL1 and VLDL2 metabolism. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:49 / 56
页数:8
相关论文
共 50 条
  • [1] Hepatic production of VLDL1 but not VLDL2 is related to insulin resistance in normoglycaemic subjects
    Gill, JMR
    Brown, JC
    Wright, DM
    Cooney, J
    Bedford, D
    Hughes, DA
    Stanley, JC
    Packard, CJ
    Caslake, MJ
    ATHEROSCLEROSIS, 2003, 169 (02) : 359 - 359
  • [2] Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects
    Malmström, R
    Packard, CJ
    Caslake, M
    Bedford, D
    Stewart, P
    Yki-Järvinen, H
    Shepherd, J
    Taskinen, MR
    DIABETES, 1998, 47 (05) : 779 - 787
  • [3] Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects (vol 47, pg 779, 1998)
    Malmström, R
    Packard, C
    Caslake, M
    Bedford, D
    Stewart, P
    Yki-Järvinen, H
    Shepherd, J
    Taskinen, MR
    DIABETES, 1998, 47 (09) : 1532 - 1532
  • [4] Basal and insulin-regulated VLDL1 and VLDL2 kinetics in men with type 2 diabetes
    Rakel F. Johansen
    Esben Søndergaard
    Lars Peter Sørensen
    Anne Grethe Jurik
    Jens S. Christiansen
    Søren Nielsen
    Diabetologia, 2016, 59 : 833 - 843
  • [5] Basal and insulin-regulated VLDL1 and VLDL2 kinetics in men with type 2 diabetes
    Johansen, Rakel F.
    Sondergaard, Esben
    Sorensen, Lars Peter
    Jurik, Anne Grethe
    Christiansen, Jens S.
    Nielsen, Soren
    DIABETOLOGIA, 2016, 59 (04) : 833 - 843
  • [6] VLDL1 and VLDL2 Triglyceride Kinetics in Type 2 Diabetic and Healthy Men
    Johansen, Rakel F.
    Sondergaard, Esben
    Sorensen, Lars Peter
    Jurik, Anne Grethe
    Christiansen, Jens S.
    Nielsen, Soren
    DIABETES, 2015, 64 : A175 - A175
  • [7] Distinct patterns of heparin affinity chromatography VLDL1 and VLDL2 subfractions in the different dyslipidaemias
    Duvillard, L.
    Caslake, M. J.
    Petit, J. M.
    Verges, B.
    Gambert, P.
    Packard, C. J.
    ATHEROSCLEROSIS, 2008, 199 (01) : 27 - 33
  • [8] Effects of rosuvastatin on the metabolism of apolipoprotein B of VLDL1, VLDL2, IDL and LDL during type 2 diabetes
    Verges, B.
    Florentin, E.
    Baillot-Rudoni, S.
    Monnier, S.
    Petit, J. M.
    Gambert, P.
    Duvillard, L.
    DIABETES & METABOLISM, 2008, 34 : A37 - A37
  • [9] Effects of moderate exercise on VLDL1 and Intralipid kinetics in overweight/obese middle-aged men
    Al-Shayji, Iqbal A. R.
    Caslake, Muriel J.
    Gill, Jason M. R.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2012, 302 (03): : E349 - E355
  • [10] Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance
    Adiels, M.
    Westerbacka, J.
    Soro-Paavonen, A.
    Haekkinen, A. M.
    Vehkavaara, S.
    Caslake, M. J.
    Packard, C.
    Olofsson, S. O.
    Yki-Jaervinen, H.
    Taskinen, M. R.
    Boren, J.
    DIABETOLOGIA, 2007, 50 (11) : 2356 - 2365